Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis.

Wang, G Y; Rayner, S L; Chung, R; Shi, B Y; Liang, X J

Wang, G Y; Rayner, S L; Chung, R; Shi, B Y; Liang, X J.

Afiliación

Wang GY; Huaihe Hospital, Henan University, Kaifeng, Henan, 475004, China.
Rayner SL; Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.
Chung R; Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.
Shi BY; Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.
Liang XJ; Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.

Mater Today Bio ; 6: 100055, 2020 Mar.

Article en En | MEDLINE | ID: mdl-32529183

Palabras clave

Amyotrophic lateral sclerosis (ALS); Blood-brain barrier; Central nervous system (CNS); Nanotechnology; Neurodegenerative diseases

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mater Today Bio Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google